Trial | NCT03183999  Report issue

Title

Effect of Fermented Ginseng (GINST) on Sperm Motility
Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Evaluation of Sperm Motility Improvement Effect of Fermented Ginseng(GINST)

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Unknown status

  • Intervention/Treatment

    ginseng ...

  • Study Participants

    60
This randomized, double-blind, placebo-controlled study aimed to evaluate the effect of ginseng(GINST) supplementation for 12 weeks on sperm motility.
This multicenter, randomized, double-blind, placebo-controlled clinical trial was aimed to evaluate of sperm motility improvement effect of fermented ginseng(GINST). Experimental arm and control arm were randomly assigned among the volunteers who met the inclusion criteria: men between the ages of 18 and 60 who had sperm motility of less than 32%.

To experimental arm, capsules including 160mg of fermented ginseng(GINST) ingredients will be provided for 12 weeks. To control arm, capsules of the same shape and weight as GINST capsules will be provided. These capsules are made of a cellulose component.

Primary outcome is sperm motility. Secondary outcome are , , and measured at baseline and end of the trial.
Study Started
Jan 26
2017
Primary Completion
Dec 01
2017
Anticipated
Study Completion
Dec 31
2017
Anticipated
Last Update
Jun 12
2017

Dietary Supplement fermented ginseng (GINST)

Intervention group should take fermented ginseng (GINST) capsule 3 times a day, 2 capsules at one time for 12 weeks

Dietary Supplement Placebo

Control group should take placebo capsule 3 times a day, 2 capsules at one time for 12 weeks

Control group Placebo Comparator

Control group was randomly assigned among the volunteers who met the inclusion criteria: men between the ages of 18 and 60 who had sperm motility of less than 32%. Placebo was supplied.

GINST group Experimental

Experimental group was randomly assigned among the volunteers who met the inclusion criteria: men between the ages of 18 and 60 who had sperm motility of less than 32%. Fermented ginseng (GINST) was supplied.

Criteria 

Inclusion Criteria:

Male between 18 and 60 years old
Men who have agreed to participate in this trial before the start of the study and who have written an informed consent

Exclusion Criteria:

Those who are diagnosed and treated for hypertension (systolic blood pressure> 140mmHg and diastolic blood pressure> 90mmHg)
Patients with a history of chemotherapy for malignant tumors
Patients with a history of taking testosterone or antiandrogens within 1 month
BMI> 30 or BMI <18
Those who have the following results in the blood test: AST(aspartate aminotransferase ), ALT(Alanine transaminase) > 2 times the upper limit of reference range; Serum Creatinine> 2.0 mg / dl
Those who ingested drugs (eg, folic acid, L-carn, HCG(human chorionic gonadotropin ), FSH(Follicle-stimulating hormone), Clomiphene, etc.) that have an effect on sperm motility within 2 weeks before the screening day.
Persons who have received antipsychotic medication within 2 months before the screening test
Those who have history of alcoholism or substance abuse
No Results Posted